Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-737P is a pseudogene that shares sequence similarity with the highly conserved U6 snRNA gene, which encodes one of the core components of the spliceosome involved in the excision of introns from pre-mRNA in eukaryotic nuclei[1][3][5]. Unlike functional U6 snRNAs, which are critical for splicing, pseudogenes such as RNU6-737P generally do not encode a functional RNA and are not known to be expressed or to have a direct biological activity[5][6]. Sequence analysis has revealed that human U6 snRNA pseudogenes show moderate sequence homology—often ~77%—to canonical U6 snRNA, sometimes with rearrangements or duplications[5]. While some pseudogenes in certain contexts can influence gene regulation (such as acting as competitive endogenous RNAs for microRNA binding or generating small interfering RNAs), there is no evidence that RNU6-737P itself plays such a role[4][6]. Its primary relevance is as a genomic artifact, rather than as a functional gene, and it is not considered a therapeutic target, receptor, enzyme, or biomarker for any disease[2][5][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 737, pseudogene (RNU6-737P).